Top 4 Stocks In The Drugs-Generic Industry With The Highest ROA

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at Akorn

is 14.50%. Akorn's PEG ratio is 1.23. The trailing-twelve-month return on assets at Hi-Tech Pharmacal Co

is 7.81%. Hi-Tech Pharmacal's operating margin for the same period is 15.88%. The trailing-twelve-month return on assets at Salix Pharmaceuticals

is 7.42%. Salix had $817.72 million in total cash for the latest quarter. The trailing-twelve-month return on assets at Mylan

is 6.73%. Mylan's revenue for the same period is $6.82 billion.